Before Jul 1, 2027
Market Model 40.0% 38.4%
Before Jan 1, 2027
Market Model 13.0% 10.1%
Medicine Markets
Active Markets (2)
Before 2027
Market Model 70.0% 66.2%
Before November
Market Model 64.0% 33.3%
| Event | Market | Model | Conf | TI | |
|---|---|---|---|---|---|
| Will the FDA approve cytisinicline for smoking cessation? Top outcome: Before Jul 1, 2027 | 40.0% | 38.4% | High | 75 | Refresh |
| When will the FDA reclassify BPC-157 to Category 1? Top outcome: Before 2027 | 70.0% | 66.2% | High | 75 | Refresh |
Expired Markets (1)
Before Jan 1, 2027
Market Model 6.0% 30.1%
Before Jan 1, 2028
Market Model 70.0% 39.7%
| Event | Market | Model | Conf | TI | |
|---|---|---|---|---|---|
| Will the FDA approve camizestrant for advanced breast cancer? Top outcome: Before Jan 1, 2027 | 6.0% | 30.1% | High | — |
